Lebrikizumab is efficacious and safe for patients with skin of color and eczema: Study

Published Date: 14 Aug 2025

For patients with skin of color and atopic dermatitis (AD), lebrikizumab is efficacious and safe, according to a study published online July 15 in the American Journal of Clinical Dermatology.

Read Full News

Latest News

Air Pollution Linked to Reduced Midlife Cognitive Function

Everyday exposure to traffic, industry, and wildfire smoke was associated with vascular brain injury in middle age.

Perinatal Grief and Disney’s Versa: Can Films Change Care?

Spanish clinicians and grief advocates stress that compassionate communication and bereavement support shape how families process perinatal loss.

Eye Care Sees Green: Recycling Comes for Contact Lens Waste

Self-Screening Tool for AxSpA Aims to Lower Diagnostic Delay

The patient self-screening tool that was developed to help identify axial spondyloarthritis promises to cut time to diagnosis and is being evaluated in a large European cohort.

Single Bevacizumab Dose Sustains Trabeculectomy Success

A single injection of bevacizumab given during glaucoma surgery is associated with improved chances of surgical success even 3 years after the operation, a follow-up study of a clinical trial shows.

For Med Students, Finding the Right Mentor Can Be a Boost

Start with your advisors to find a mentor in your specialty or in another.

Todays Updates

EMA Backs Breast Cancer SERD After FDA No Vote

The recommendation follows phase 3 data showing longer progression-free survival when patients switched to camizestrant plus a CDK4/6 inhibitor.

Datopotamab Deruxtecan Earns New Breast Cancer Indication

The antibody drug conjugate was approved by the FDA for certain patients with triple-negative breast cancer.

Todays Updates

EMA Backs Breast Cancer SERD After FDA No Vote

The recommendation follows phase 3 data showing longer progression-free survival when patients switched to camizestrant plus a CDK4/6 inhibitor.

Datopotamab Deruxtecan Earns New Breast Cancer Indication

The antibody drug conjugate was approved by the FDA for certain patients with triple-negative breast cancer.

Latest News

Everyday exposure to traffic, industry, and wildfire smoke was associated with vascular brain injury in middle age.

Spanish clinicians and grief advocates stress that compassionate communication and bereavement support shape how families process perinatal loss.

The patient self-screening tool that was developed to help identify axial spondyloarthritis promises to cut time to diagnosis and is being evaluated in a large European cohort.

A single injection of bevacizumab given during glaucoma surgery is associated with improved chances of surgical success even 3 years after the operation, a follow-up study of a clinical trial shows.

Start with your advisors to find a mentor in your specialty or in another.

News All Time

IA Thrombolysis After Thrombectomy: More Uncertainty

The TECNO trial finds no clear reperfusion benefit from intra-arterial thrombolysis after thrombectomy in acute ischemic stroke, raising fresh doubts about the strategy.

Aging in Hospital Medicine: How to Retain Older Hospitalists

The schedule and demanding nature of the job make hospitalist jobs more difficult as you age. Some systems are trying to help.

Soccer-Study Warns Of Dangerous Heat At 2026 World Cup as Climate Risks Grow

Football's global players' union renewed concerns on Thursday about heat at the 2026 World Cup after scientists warned the likelihood of dangerous temperatures for players...

Is Flare Prophylaxis Always Needed When Starting Gout Drugs?

There are divided opinions over whether anti-inflammatory drugs should always be used when initiating urate-lowering therapy for gout. Would a ‘pill in the pocket’ approach be better?

CMV Infection in Early Pregnancy Tied to Autism Risk in Kids

Children with congenital cytomegalovirus infection may experience complications such as autism and hearing loss if their mothers have a first-time infection during the first trimester.

Medicine Through Film: 10 Classics for Clinicians

Ten cinematic classics trace medicine’s moral, social, and scientific dilemmas — a curated watchlist that highlights storytelling, stigma, and a call for female leads.

Corticosteroids May Raise Risk for Mortality in IPF

The use of corticosteroids is linked to a higher risk for mortality in patients with acute exacerbations of idiopathic pulmonary fibrosis.

Mollicute Screening Improves Outcomes After Lung Transplant

Donor-recipient RNA assay significantly reduced the days to diagnosis of infection.

Hung Up on Hantavirus? How to Answer If Patients Are Asking

Recent outbreak on a Dutch cruise ship poses no risk to public at large, experts say.

Could AI Copilots Reduce Clinician Documentation Time?

Ambient AI systems may reduce documentation demands and allow physicians to spend more time interacting directly with patients during their visits.

Hantavirus-hit Cruise Ship Heads to Spain After Three People Evacuated

A luxury cruise ship hit by a deadly hantavirus outbreak and marooned since Sunday off the coast of Cape Verde left for Spain on Wednesday, a Reuters witness said, after...

German Woman on Hantavirus-Hit Ship to Be Tested in Germany

A German national who had contact with an infected person onboard a cruise ship hit by hantavirus will be brought to a hospital in the German city of Duesseldorf for ⁠testing.

Hantavirus-hit Cruise Ship to Head to Spain After Permission Granted to Dock in Canary Islands

A luxury cruise ship that has been hit by an outbreak of the deadly hantavirus was preparing to travel from Cape Verde towards Europe on Wednesday after the Spanish...

COVID Tx Failed to Curb Hospitalization in High-Risk Adults

Treatment was associated with reduced viral load compared with usual care.

Convicted Former Harvard Scientist Rebuilds Brain Computer Lab in China

An American scientist convicted of lying to U.S. authorities about payments from China while he was at Harvard University has rebuilt his research lab in Shenzhen to pursue...

‘Living’ Database Tracks Psilocybin Trials for Depression

Sypres.io continuously tracks and evaluates psychedelic research, offering an up-to date view of study findings, design, and limitations.

Recommended News For You

Should the UK introduce targeted prostate cancer screening? The case for and against

Positive Trials; Malignancies Increasing in Younger Adults; Andre Braugher's Cancer Dx.

PFS in Multiple Myeloma Is Improved by Daratumumab Added to Standard Therapy.

Fear of hair loss might cause some to reject cancer treatment

Telemedicine services linked to reducing excess mortality

How the skin cancer virus outperforms the replication of host cells.

MET Inhibitor Increases Osimertinib Activity in EGFR+ Advanced NSCLC

Recommended Articles For You

Unlocking the Power of Hematocrit: Exploring the Benefits of Blood Cell Counts 

Inside Oncology Trials: From Protocol to Progress in Cancer Research and Care 

Radiation in Oncology: Advances, Applications, and Accessibility 

Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Breast Cancer Patients Living Longer Post-Medicaid Expansion

2.

Error on the MGUS-Autoimmune Disease Association.

3.

Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.

4.

The majority of cancer medications that receive expedited approval end up failing confirmatory trials.

5.

Unified Neuro/Psych Residency Program: New Proposal.

1.

Optimizing Melanoma Treatment: Strategies in Diagnosis, Clinical Research, and Physician Training

2.

Hemoglobin C: Understanding its Role in Sickle Cell Disease

3.

Beyond the Human Eye: How AI Is Redefining Brain Cancer Diagnosis Through Advanced Imaging

4.

Understanding Abemaciclib: A Breakthrough Treatment for Breast Cancer 

5.

The Growing Challenge of Haematological Malignancies in Older Adults

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II

2.

Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial

3.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII

4.

A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC

5.

Efficient Management of First line ALK-rearranged NSCLC - Part VI

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot